Publications
Nature CancerNov 2021 |
2
(
11
),
1224-1242
DOI:
10.1038/s43018-021-00259-9

Proteogenomics of non-small cell lung cancer reveals molecular subtypes associated with specific therapeutic targets and immune-evasion mechanisms

Lehtiö, Janne; Arslan, Taner; Siavelis, Ioannis; Pan, Yanbo; Socciarelli, Fabio; Berkovska, Olena; Umer, Husen M.; Mermelekas, Georgios; Pirmoradian, Mohammad; Jönsson, Mats; Brunnström, Hans; Brustugun, Odd Terje; Purohit, Krishna Pinganksha; Cunningham, Richard; Foroughi Asl, Hassan; Isaksson, Sofi; Arbajian, Elsa; Aine, Mattias; Karlsson, Anna; Kotevska, Marija; Gram Hansen, Carsten; Drageset Haakensen, Vilde; Helland, Åslaug; Tamborero, David; Johansson, Henrik J.; Branca, Rui M.; Planck, Maria; Staaf, Johan; Orre, Lukas M.
Product Used
Genes
Abstract
DIA-MS analysis and k-TSP based classification of NSCLC Validation and late-stage cohorts. A. DIA-MS analysis of the 208 samples in the NSCLC validation cohort resulted in the identification of 7,379 proteins (FDR 
Product Used
Genes

Related Publications